XW0Q35CIntroduction of Ifezuntirgene Inilparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 12

New Technology›Anatomical Regions›Introduction
ICD-10-PCS XW0Q35C
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XW0Q35C is a billable ICD-10-PCS procedure code for Introduction of Ifezuntirgene Inilparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 12. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products. The Alphabetic Index lists this code under Ifezuntirgene Inilparvovec.

Code Identity

ICD-10-PCS Code
XW0Q35C
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Ifezuntirgene Inilparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 12
Short Description
Introduce Ifezn Inparv in Cranial/Brain, Perc, New Tech 12
Parent Code
XW0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPartQCranial Cavity and Brain
5Approach3Percutaneous
6Device/Substance/Technology5Ifezuntirgene Inilparvovec
7QualifierCNew Technology Group 12

In the ICD-10-PCS Alphabetic Index

The FY 2027 ICD-10-PCS Alphabetic Index refers to XW0Q35C as Ifezuntirgene Inilparvovec. These index entries lead to this code:

Ifezuntirgene Inilparvovec
Direct entry for this code
New Technology, Ifezuntirgene Inilparvovec
Direct entry for this code
Iloprost
Leads to this code's table
Sarilumab
Leads to this code's table
Posoleucel
Leads to this code's table
Rezafungin
Leads to this code's table
Treosulfan
Leads to this code's table
Baricitinib
Leads to this code's table
Sabizabulin
Leads to this code's table
Tocilizumab
Leads to this code's table
Caplacizumab
Leads to this code's table
COVID-19 Vaccine
Leads to this code's table
Inebilizumab-cdon
Leads to this code's table
Sulbactam-Durlobactam
Leads to this code's table
CD24Fc Immunomodulator
Leads to this code's table

To code ifezuntirgene inilparvovec, open the FY 2027 ICD-10-PCS Alphabetic Index at Ifezuntirgene Inilparvovec. The entry lists XW0Q35C directly as a complete, billable code.

Browse the full ICD-10-PCS Alphabetic Index →

Code History

FY 2027New code, effective October 1, 2026.
Replaces previously assigned code(s):
  • 3E0Q3GC — Introduce Oth Therap Subst in Cran Cav/Brain, Perc

Similar Procedure Codes

Questions About XW0Q35C

Is XW0Q35C a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Ifezuntirgene Inilparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 12 on inpatient claims from October 1, 2026 through September 30, 2027.

What is the ICD-10-PCS code for ifezuntirgene Inilparvovec?

The ICD-10-PCS Alphabetic Index lists Ifezuntirgene Inilparvovec under code XW0Q35C, Introduction of Ifezuntirgene Inilparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 12, billable on inpatient claims in fiscal year 2027.

What do the characters in XW0Q35C mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character Q is the BodyPart (Cranial Cavity and Brain); the 5th character 3 is the Approach (Percutaneous); the 6th character 5 is the Device/Substance/Technology (Ifezuntirgene Inilparvovec); the 7th character C is the Qualifier (New Technology Group 12).